FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

395763007: Ispaghula husk (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1469703018 Ispaghula husk (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1489405017 Ispaghula husk en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2476990019 Psyllium husk en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3036900016 Psyllium mucilloid en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3197331000005119 loppefrøskaller da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ispaghula husk (substance) Is a Psyllium seed true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Ispaghula husk [gastro-intestinal bulk laxative] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ispaghula husk (substance) Inferred relationship Some
loppefrøskaller 3,4 g/brev sukkerfrit pulver The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ispaghula husk (substance) Inferred relationship Some
loppefrøskaller 6 g/brev sukkerfrit pulver The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ispaghula husk (substance) Inferred relationship Some
Ispaghula husk lemon/lime 3.4g/sachet s/f powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ispaghula husk (substance) Inferred relationship Some
Ispaghula husk orange 3.4g/sachet s/f powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ispaghula husk (substance) Inferred relationship Some
Ispaghula husk orange 3.5g/sachet s/f granules The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ispaghula husk (substance) Inferred relationship Some
Ispaghula husk lemon 3.5g/sachet s/f granules The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ispaghula husk (substance) Inferred relationship Some
loppefrøskaller 3,5 g brev sukkerfrit granulat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ispaghula husk (substance) Inferred relationship Some
Product containing precisely ispaghula husk 900 milligram/1 gram granules for conventional release oral suspension (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ispaghula husk (substance) Inferred relationship Some
Ispaghula husk 56% powder 6.4g The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ispaghula husk (substance) Inferred relationship Some
Ispaghula husk [lipid lowering use] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ispaghula husk (substance) Inferred relationship Some
Ispaghula husk orange 3.5g s/f granules The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ispaghula husk (substance) Inferred relationship Some
loppefrøskaller pulver The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ispaghula husk (substance) Inferred relationship Some
loppefrøskalsgranulat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ispaghula husk (substance) Inferred relationship Some
Product containing ispaghula husk (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ispaghula husk (substance) Inferred relationship Some 1
Ispaghula husk agent The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ispaghula husk (substance) Inferred relationship Some
Ispaghula husk 3.5g/sachet s/f powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ispaghula husk (substance) Inferred relationship Some
loppefrøskaller 3,5 g glutenfrit, sukkerfrit brusesgranulat i brev The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ispaghula husk (substance) Inferred relationship Some
sennes 12,4 % + loppefrø 54,2 % granulat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ispaghula husk (substance) Inferred relationship Some
Product containing psyllium and senna (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ispaghula husk (substance) Inferred relationship Some
loppefrøskaller 3,5 g/brev sukkerfrit pulver The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ispaghula husk (substance) Inferred relationship Some
Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ispaghula husk (substance) Inferred relationship Some
Product containing ispaghula husk and mebeverine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ispaghula husk (substance) Inferred relationship Some 1
Ispaghula husk 3.4g/sachet conventional release oral powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ispaghula husk (substance) Inferred relationship Some
Ispaghula husk 3.5g/sachet conventional release oral powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ispaghula husk (substance) Inferred relationship Some
Ispaghula husk 3.5g/sachet granules The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ispaghula husk (substance) Inferred relationship Some
Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Ispaghula husk (substance) Inferred relationship Some 1
Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ispaghula husk (substance) Inferred relationship Some 1
Product containing precisely ispaghula husk 3.5 gram/1 sachet granules for conventional release oral suspension (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Ispaghula husk (substance) Inferred relationship Some 1
Product containing precisely ispaghula husk 3.5 gram/1 sachet granules for conventional release oral suspension (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ispaghula husk (substance) Inferred relationship Some 1
Ispaghula husk 6 g powder for oral suspension sachet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Ispaghula husk (substance) Inferred relationship Some 1
Ispaghula husk 6 g powder for oral suspension sachet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ispaghula husk (substance) Inferred relationship Some 1
Product containing precisely ispaghula husk 900 milligram/1 gram granules for conventional release oral suspension (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ispaghula husk (substance) Inferred relationship Some 1
Product containing precisely ispaghula husk 900 milligram/1 gram granules for conventional release oral suspension (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Ispaghula husk (substance) Inferred relationship Some 1
Product containing ispaghula husk and mebeverine in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ispaghula husk (substance) Inferred relationship Some 1
Ispaghula husk-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ispaghula husk (substance) Inferred relationship Some 1
Product containing only ispaghula husk (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ispaghula husk (substance) Inferred relationship Some 1
Ispaghula husk and mebeverine only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ispaghula husk (substance) Inferred relationship Some 1
Ispaghula husk and mebeverine only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ispaghula husk (substance) Inferred relationship Some 1
Product containing only ispaghula husk in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ispaghula husk (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start